Literature DB >> 11170878

Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms.

J S Lindholt1, N H Heegaard, S Vammen, H Fasting, E W Henneberg, L Heickendorff.   

Abstract

OBJECTIVES: to study the role of smoking, lipids, lipoprotein (a), and autoantibodies against oxidised low density lipoprotein (Ab-oxLDL) in the expansion of small abdominal aortic aneurysms (AAA). To study the role of Ab-oxLDL and lp(a) in the progression of lower limb atherosclerosis. METHODS AND MATERIALS: one hundred and thirty-eight male patients with AAA were interviewed, examined, and their serum lipids and S-Ab-oxLDL determined. Of these, 117 were followed annually with ultrasound and underwent control scans and blood pressure measurements for a mean of 2.5 (range 1-5) years.
RESULTS: initial AAA size, smoking and level of triglycerides were positively correlated to increased aneurysmal expansion, while beta-blocker medication was associated with decreased expansion. Besides initial AAA size, only smoking had persisting significance after adjustment of the other significant variables. Initial ankle brachial pressure index (ABI) and Lp(A) but not ab-oxLDL were significantly correlated to ABI change.
CONCLUSION: smoking cessation may inhibit aneurysmal expansion. Lipids seem to play a minor role in the progression of AAA. Copyright 2001 Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170878     DOI: 10.1053/ejvs.2000.1262

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  17 in total

1.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.

Authors:  Stephanie Schulte; Jiusong Sun; Peter Libby; Lindsey Macfarlane; Chongxiu Sun; Marco Lopez-Ilasaca; Guo-Ping Shi; Galina K Sukhova
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  On the potential increase of the oxidative stress status in patients with abdominal aortic aneurysm.

Authors:  J Pincemail; J O Defraigne; J P Cheramy-Bien; N Dardenne; A F Donneau; A Albert; N Labropoulos; N Sakalihasan
Journal:  Redox Rep       Date:  2012-06-21       Impact factor: 4.412

3.  Abdominal aortic diameter and vascular atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  G A Laughlin; M A Allison; N E Jensky; V Aboyans; N D Wong; R Detrano; M H Criqui
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-01-14       Impact factor: 7.069

Review 4.  Pathology, natural history and treatment of abdominal aortic aneurysms.

Authors:  A R Zankl; H Schumacher; U Krumsdorf; H A Katus; L Jahn; C P Tiefenbacher
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

5.  Management of Abdominal Aortic Aneurysms.

Authors:  Jennifer M Dehlin; Gilbert R Upchurch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-06

6.  Growth patterns of abdominal atherosclerotic calcified deposits from lumbar lateral X-rays.

Authors:  Lene Lillemark; Melanie Ganz; Natasha Barascuk; Erik B Dam; Mads Nielsen
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-03       Impact factor: 2.357

Review 7.  Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects.

Authors:  Joseph V Moxon; Adam Parr; Theophilus I Emeto; Philip Walker; Paul E Norman; Jonathan Golledge
Journal:  Curr Probl Cardiol       Date:  2010-10       Impact factor: 5.200

8.  Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.

Authors:  Menggui Huang; Yanqing Gong; Jessica Grondolsky; Jane Hoover-Plow
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

Review 9.  Medical management of small abdominal aortic aneurysms.

Authors:  B Timothy Baxter; Michael C Terrin; Ronald L Dalman
Journal:  Circulation       Date:  2008-04-08       Impact factor: 29.690

10.  Autoreactive T Cells in Human Smokers is Predictive of Clinical Outcome.

Authors:  Chuang Xu; Sean Hesselbacher; Chu-Lin Tsai; Ming Shan; Margaret Spitz; Michael Scheurer; Luz Roberts; Sarah Perusich; Nazanin Zarinkamar; Harvey Coxson; Natasha Krowchuk; David B Corry; Farrah Kheradmand
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.